GlassScriptPhysician profile
Molly B Toda
NPI 1245635184
$545.82
in general payments reported to CMS, 2019-2025
15 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.10 · 2023: $151 · 2024: $185 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $108.43 | 2024-2025 | Doc Band |
| Glaxosmithkline, LLC. | $92.89 | 2023-2025 | Bexsero, Rotarix |
| Pfizer INC. | $55.04 | 2023-2024 | |
| Alk-Abello, INC | $48.45 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $46.45 | 2024-2025 | Gardasil 9, Vaqta, Vaxelis |
| Ironshore Pharmaceuticals INC. | $34.64 | 2023-2024 | Jornay Pm |
| Avion Pharmaceuticals | $24.73 | 2023 | Methylphenidate Hydrochloride |
| Hologic Sales and Service, LLC | $21.08 | 2025 | Aptima |
| Ironwood Pharmaceuticals, INC | $20.81 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $18.90 | 2025 | Neffy |
| Kaleo, INC. | $17.09 | 2024 | Auvi-Q |
| Novo Nordisk INC | $16.55 | 2024 | |
| Tris Pharma INC | $14.90 | 2021 | |
| Sanofi Pasteur INC. | $14.66 | 2023 | |
| Neos Therapeutics, LP | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Toda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.